2297 Share Price Performance
HK$0.28
0.12 (78.12%)
Price HK$0.28
Share Pricen/a
Rainmed Medical Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
2297 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Rainmed Medical Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.074
- 44.22%
- -445.27%
- 7.8%
About 2297
- Founded
- 2014
- Employees
- 214
- CEO
- WebsiteView website
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coronary artery ischemia severity based on coronary angiography images; and caIMR System, including FlashAngio caIMR System and FlashPressure caIMR pressure transducer, which is a less-invasive index of microcirculatory resistance measurement product for the treatment of microcirculatory lesions. Rainmed Medical Limited was founded in 2014 and is headquartered in Suzhou, China.
